René A. Adam

Q: What Schools Are Affiliated With René A. Adam

René A. Adam is affiliated with the following schools: Paris-Saclay University, University of Geneva, University of Vienna, University of Southampton

René A. Adam's AcademicInfluence.com Rankings

René A. Adam

Medical

#1825

World Rank

#2202

Historical Rank

Oncology

#97

World Rank

#101

Historical Rank

medical Degrees

René A. Adam

Philosophy

#5439

World Rank

#8238

Historical Rank

Logic

#2723

World Rank

#3754

Historical Rank

philosophy Degrees

Download Badge

Medical
Philosophy

René A. Adam's Degrees

Doctorate Medicine Université Paris Cité
PhD Oncology Université Paris Cité

Why Is René A. Adam Influential?

(Suggest an Edit or Addition)

(See a Problem?)

René A. Adam's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. (2016) (2368)
Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. (2009) (1584)
Posthepatectomy liver failure: a definition and grading by the International Study Group of Liver Surgery (ISGLS). (2011) (1560)
Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy: A Model to Predict Long-term Survival (2004) (1454)
Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. (2011) (1204)
Tumor Progression While on Chemotherapy: A Contraindication to Liver Resection for Multiple Colorectal Metastases? (2004) (1000)
Resection of nonresectable liver metastases from colorectal cancer after neoadjuvant chemotherapy. (1996) (950)
Liver Resection Versus Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients (1993) (854)
Evolution of indications and results of liver transplantation in Europe. A report from the European Liver Transplant Registry (ELTR). (2012) (736)
Two-Stage Hepatectomy: A Planned Strategy to Treat Irresectable Liver Tumors (2000) (732)
Liver transplantation for hepatocellular carcinoma: a model including α-fetoprotein improves the performance of Milan criteria. (2012) (668)
Long-term survival of patients with unresectable colorectal cancer liver metastases following infusional chemotherapy with 5-fluorouracil, leucovorin, oxaliplatin and surgery. (1999) (633)
Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases (2001) (586)
Evolution of liver transplantation in Europe: Report of the European Liver Transplant Registry (2003) (558)
Resection of nonresectable liver metastases from colorectal cancer after percutaneous portal vein embolization. (2000) (526)
Patients with initially unresectable colorectal liver metastases: is there a possibility of cure? (2009) (525)
Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis. (1997) (523)
Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement (2006) (521)
Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases. (2006) (498)
Towards a pan-European consensus on the treatment of patients with colorectal liver metastases. (2006) (497)
Efficacy and safety of selective internal radiotherapy with yttrium-90 resin microspheres compared with sorafenib in locally advanced and inoperable hepatocellular carcinoma (SARAH): an open-label randomised controlled phase 3 trial. (2017) (479)
The oncosurgery approach to managing liver metastases from colorectal cancer: a multidisciplinary international consensus. (2012) (449)
Liver transplantation for hepatocellular carcinoma. (1999) (447)
Hepatic Resection for Noncolorectal Nonendocrine Liver Metastases: Analysis of 1452 Patients and Development of a Prognostic Model (2006) (431)
Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus. (2015) (399)
Repeat hepatectomy for colorectal liver metastases. (1997) (398)
R1 Resection by Necessity for Colorectal Liver Metastases: Is It Still a Contraindication to Surgery? (2008) (397)
Liver Resection as a Bridge to Transplantation for Hepatocellular Carcinoma on Cirrhosis: A Reasonable Strategy? (2003) (395)
Liver Resection for Colorectal Metastases: The Third Hepatectomy (2003) (386)
Five-year survival following hepatic resection after neoadjuvant therapy for nonresectable colorectal. (2001) (353)
A chronopharmacologic phase II clinical trial with 5‐fluorouracil, folinic acid, and oxaliplatin using an ambulatory multichannel programmable pump. High antitumor effectiveness against metastatic colorectal cancer (1992) (332)
3-month and 12-month mortality after first liver transplant in adults in Europe: predictive models for outcome (2006) (328)
Post-hepatectomy haemorrhage: a definition and grading by the International Study Group of Liver Surgery (ISGLS). (2011) (313)
Long-Term Results of Two-Stage Hepatectomy for Irresectable Colorectal Cancer Liver Metastases (2008) (305)
Sirolimus Use in Liver Transplant Recipients With Hepatocellular Carcinoma: A Randomized, Multicenter, Open-Label Phase 3 Trial (2015) (301)
Liver Transplantation for Alcoholic Liver Disease in Europe: A Study from the ELTR (European Liver Transplant Registry) (2010) (289)
Complete pathologic response after preoperative chemotherapy for colorectal liver metastases: myth or reality? (2008) (284)
Oncologic Results of Laparoscopic Versus Open Hepatectomy for Colorectal Liver Metastases in Two Specialized Centers (2009) (274)
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group. (2007) (270)
Place of cryosurgery in the treatment of malignant liver tumors. (1997) (265)
Normalised intrinsic mortality risk in liver transplantation: European Liver Transplant Registry study (2000) (259)
The outcome of steatotic grafts in liver transplantation. (1991) (256)
OncoSurge: a strategy for improving resectability with curative intent in metastatic colorectal cancer. (2005) (249)
2018 Annual Report of the European Liver Transplant Registry (ELTR) – 50‐year evolution of liver transplantation (2018) (247)
Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial. (2015) (247)
The Eurotransplant Donor Risk Index in Liver Transplantation: ET‐DRI (2012) (244)
Liver Transplantation for Hereditary Transthyretin Amyloidosis: After 20 Years Still the Best Therapeutic Alternative? (2015) (244)
Progression of Alphafetoprotein Before Liver Transplantation for Hepatocellular Carcinoma in Cirrhotic Patients: A Critical Factor (2010) (234)
Chemotherapy and surgery: new perspectives on the treatment of unresectable liver metastases. (2003) (233)
Liver resection of colorectal metastases in elderly patients (2010) (226)
Phase I trial of 5-day continuous venous infusion of oxaliplatin at circadian rhythm-modulated rate compared with constant rate. (1990) (222)
Role of neoadjuvant chemotherapy in the treatment of multiple colorectal metastases to the liver (2003) (213)
Liver transplantation for acute liver failure in Europe: outcomes over 20 years from the ELTR database. (2012) (210)
Documented deaths of hepatic lobe donors for living donor liver transplantation (2006) (209)
Is Liver Resection Justified for Patients With Hepatic Metastases From Breast Cancer? (2006) (206)
Liver transplantation for Budd-Chiari syndrome: A European study on 248 patients from 51 centres. (2006) (204)
Hepatic resection after rescue cetuximab treatment for colorectal liver metastases previously refractory to conventional systemic therapy. (2007) (200)
Effect of extended cold ischaemia with UW solution on graft function after liver transplantation (1992) (198)
Liver Transplantation for Neuroendocrine Tumors in Europe—Results and Trends in Patient Selection: A 213-Case European Liver Transplant Registry Study (2013) (190)
Split-liver transplantation. The Paul Brousse policy. (1996) (184)
A comparison of percutaneous cryosurgery and percutaneous radiofrequency for unresectable hepatic malignancies. (2002) (183)
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? (2008) (179)
Specific vascular complications of orthotopic liver transplantation with preservation of the retrohepatic vena cava: review of 1361 cases. (1999) (179)
Is Perioperative Chemotherapy Useful for Solitary, Metachronous, Colorectal Liver Metastases? (2010) (178)
Decision for Retransplantation of the Liver: An Experience- and Cost-Based Analysis (2002) (174)
Impact of DAAs on liver transplantation: Major effects on the evolution of indications and results. An ELITA study based on the ELTR registry. (2018) (171)
Early Recurrence After Liver Resection for Colorectal Metastases: Risk Factors, Prognosis, and Treatment. A LiverMetSurvey-Based Study of 6,025 Patients (2014) (169)
Impact of Expanding Criteria for Resectability of Colorectal Metastases on Short- and Long-Term Outcomes After Hepatic Resection (2011) (167)
In Situ Hypothermic Perfusion of the Liver Versus Standard Total Vascular Exclusion for Complex Liver Resection (2005) (167)
The Place of Liver Transplantation in the Treatment of Hepatic Epitheloid Hemangioendothelioma: Report of the European Liver Transplant Registry (2007) (166)
Split-Liver Transplantation for Two Adult Recipients: Feasibility and Long-Term Outcomes (2001) (166)
Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study (2019) (164)
Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus (2007) (160)
Neoadjuvant chemotherapy for initially unresectable intrahepatic cholangiocarcinoma (2018) (158)
Liver Transplantation for Hereditary Hemorrhagic Telangiectasia: Report of the European Liver Transplant Registry (2005) (155)
Urgent need for a new staging system in advanced colorectal cancer. (2008) (151)
Biweekly intensified ambulatory chronomodulated chemotherapy with oxaliplatin, fluorouracil, and leucovorin in patients with metastatic colorectal cancer. (1996) (150)
A prospective randomised, open-labeled, trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (148)
The Use of Fatty Liver Grafts in Modern Allocation Systems: Risk Assessment by the Balance of Risk (BAR) Score (2012) (143)
Neoadjuvant chemotherapy for metastatic colon cancer: a cautionary note. (2005) (140)
Combined Liver Resection and Reconstruction of the Supra-Renal Vena Cava: The Paul Brousse Experience (2006) (139)
Defining Benchmarks in Liver Transplantation: A Multicenter Outcome Analysis Determining Best Achievable Results (2017) (139)
Liver transplantation: the current situation. (2009) (139)
Intention‐to‐treat analysis of liver transplantation for hepatocellular carcinoma: Living versus deceased donor transplantation (2011) (138)
Comparison of simultaneous or delayed liver surgery for limited synchronous colorectal metastases (2010) (137)
Concomitant Extrahepatic Disease in Patients With Colorectal Liver Metastases: When Is There a Place for Surgery? (2011) (132)
Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma (2019) (121)
Effect of specialist decision‐making on treatment strategies for colorectal liver metastases (2012) (121)
A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation (2016) (121)
Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry (2015) (117)
Posthepatectomy Portal Vein Pressure Predicts Liver Failure and Mortality after Major Liver Resection on Noncirrhotic Liver (2013) (113)
Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study (2020) (113)
Effects of 10 Minutes of Ischemic Preconditioning of the Cadaveric Liver on the Graft's Preservation and Function: The Ying and the Yang (2005) (110)
Two-stage hepatectomy approach for initially unresectable colorectal hepatic metastases. (2007) (108)
Validation of the donor risk index in orthotopic liver transplantation within the Eurotransplant region (2012) (104)
A Survival Analysis of the Liver-First Reversed Management of Advanced Simultaneous Colorectal Liver Metastases: A LiverMetSurvey-Based Study (2012) (102)
Longitudinal prospective evaluation of quality of life in adult patients before and one year after liver transplantation (2003) (102)
The place of liver transplantation in Caroli's disease and syndrome (2006) (101)
Hepatic Resection for Metastatic Renal Tumors: Is It Worthwhile? (2003) (100)
Cetuximab plus Gemcitabine-Oxaliplatin (GEMOX) in Patients with Refractory Advanced Intrahepatic Cholangiocarcinomas (2007) (99)
Neurological improvement during bioartificial liver sessions in patients with acute liver failure awaiting transplantation. (2002) (97)
Risk Adjustment in ALPPS Is Associated With a Dramatic Decrease in Early Mortality and Morbidity (2017) (95)
Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes? (2016) (95)
Liver transplantation for HBV-related cirrhosis in Europe: an ELTR study on evolution and outcomes. (2013) (94)
Hepatobiliary scintigraphy to evaluate liver function in associating liver partition and portal vein ligation for staged hepatectomy: Liver volume overestimates liver function (2017) (94)
Ischemic preconditioning for major liver resection under vascular exclusion of the liver preserving the caval flow: a randomized prospective study. (2006) (92)
Hepatic colorectal metastases: methods of improving resectability. (2004) (91)
Regional treatment of metastasis: surgery of colorectal liver metastases. (2004) (91)
Surgical management of patients with colorectal cancer and simultaneous liver and lung metastases (2015) (91)
Liver transplantation for colorectal liver metastasis: Survival without recurrence can be achieved (2017) (88)
Conversion to resection of liver metastases from colorectal cancer with hepatic artery infusion of combined chemotherapy and systemic cetuximab in multicenter trial OPTILIV. (2016) (87)
Does pathological response after transarterial chemoembolization for hepatocellular carcinoma in cirrhotic patients with cirrhosis predict outcome after liver resection or transplantation? (2015) (87)
Early and Long-term Oncological Outcomes After Laparoscopic Resection for Colorectal Liver Metastases: A Propensity Score-based Analysis. (2015) (86)
Colorectal cancer with synchronous liver metastases (2007) (86)
Multidisciplinary approach of liver metastases from colorectal cancer (2019) (85)
Resection or Transplantation for Early Hepatocellular Carcinoma in a Cirrhotic Liver: Does Size Define the Best Oncological Strategy? (2012) (83)
Consensus conference: Indications for Liver Transplantation, January 19 and 20, 2005, Lyon‐Palais Des Congrès (2006) (79)
Fungal infections after liver transplantation: outcomes and risk factors revisited in the MELD era (2013) (79)
Plasma disappearance rate of indocyanine green: A tool to evaluate early graft outcome after liver transplantation (2009) (74)
Hepatic Hemangiosarcoma: An Absolute Contraindication to Liver Transplantation—The European Liver Transplant Registry Experience (2013) (74)
New Paradigms in Post-hepatectomy Liver Failure (2013) (74)
Early Recurrence After Hepatectomy for Colorectal Liver Metastases: What Optimal Definition and What Predictive Factors? (2016) (73)
Primary liver transplantation for autoimmune hepatitis: A comparative analysis of the European Liver Transplant Registry (2010) (73)
Toward optimized front-line therapeutic strategies in patients with metastatic colorectal cancer--an expert review from the International Congress on Anti-Cancer Treatment (ICACT) 2009. (2010) (72)
Recurrence of hepatocellular carcinoma after liver transplantation: Is there a place for resection? (2017) (72)
Therapeutic Strategies in Symptomatic Portal Biliopathy (2007) (71)
Simultaneous Versus Delayed Resection for Initially Resectable Synchronous Colorectal Cancer Liver Metastases (2020) (70)
Strict Selection Alone of Patients Undergoing Liver Transplantation for Hilar Cholangiocarcinoma Is Associated with Improved Survival (2016) (69)
Liver transplantation for colorectal liver metastases: revisiting the concept (2010) (69)
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. (2012) (69)
Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study (2011) (69)
Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy (1999) (68)
COVID-19 in liver transplant recipients: preliminary data from the ELITA/ELTR registry (2020) (68)
Progression while Receiving Preoperative Chemotherapy Should Not Be an Absolute Contraindication to Liver Resection for Colorectal Metastases (2012) (67)
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry (2006) (66)
Liver transplantation for primary and metastatic liver cancers (2008) (66)
Hepatic Epithelioid Hemangioendothelioma and Adult Liver Transplantation: Proposal for a Prognostic Score Based on the Analysis of the ELTR-ELITA Registry (2017) (65)
Factors influencing recurrence following initial hepatectomy for colorectal liver metastases (2016) (64)
Caval Inflow to the Graft for Liver Transplantation in Patients With Diffuse Portal Vein Thrombosis: A 12-Year Experience (2011) (64)
Regenerative Nodular Hyperplasia of the Liver Related to Chemotherapy: Impact on Outcome of Liver Surgery for Colorectal Metastases (2010) (63)
Options for elective treatment of portal hypertension in cirrhotic patients in the transplantation era. (1990) (62)
Acquired KRAS mutations during progression of colorectal cancer metastases: possible implications for therapy and prognosis (2010) (62)
Improved Survival in Liver Transplant Recipients Receiving Prolonged‐Release Tacrolimus in the European Liver Transplant Registry (2015) (62)
Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation (2011) (62)
Liver transplantation for erythropoietic protoporphyria in Europe (2011) (59)
FATAL ACUTE HIV INFECTION WITH APLASTIC ANAEMIA, TRANSMITTED BY LIVER GRAFT (1988) (57)
Donor age influences 10-year liver graft histology independently of hepatitis C virus infection. (2004) (57)
Domino liver transplants for metabolic disorders: experience with familial amyloidotic polyneuropathy. (1999) (56)
Rescue chemotherapy using multidrug chronomodulated hepatic arterial infusion for patients with heavily pretreated metastatic colorectal cancer (2009) (56)
Surgery of Colorectal Liver Metastases: Pushing the Limits (2016) (55)
Developing strategies for liver metastases from colorectal cancer. (2007) (55)
Liver transplantation for hepatocellular carcinoma: The impact of human immunodeficiency virus infection (2011) (53)
Quality control of the European Liver Transplant Registry: results of audit visits to the contributing centers (2003) (53)
Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS). (2021) (53)
Two-Stage Hepatectomy Versus 1-Stage Resection Combined With Radiofrequency for Bilobar Colorectal Metastases: A Case-Matched Analysis of Surgical and Oncological Outcomes (2014) (52)
Arterial Lactate Concentration at the End of an Elective Hepatectomy Is an Early Predictor of the Postoperative Course and a Potential Surrogate of Intraoperative Events. (2015) (52)
Long‐term outcomes after hepatic resection for colorectal metastases in young patients (2009) (52)
Failure to Achieve a 2-Stage Hepatectomy for Colorectal Liver Metastases: How to Prevent It? (2015) (52)
Outcome following hepatic resection of metastatic renal tumors: the Paul Brousse Hospital experience. (2006) (52)
Liver Metastases From Breast Cancer: What Role for Surgery? Indications and Results (2017) (50)
Survival after associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) for advanced colorectal liver metastases: A case‐matched comparison with palliative systemic therapy (2017) (49)
Drop-out between the two liver resections of two-stage hepatectomy. Patient selection or loss of chance? (2016) (49)
Cetuximab and circadian chronomodulated chemotherapy as salvage treatment for metastatic colorectal cancer (mCRC): safety, efficacy and improved secondary surgical resectability (2011) (49)
Deleterious effect of extended cold ischemia time on the posttransplant outcome of aged livers. (1995) (48)
Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes. (2013) (48)
Liver Retransplantation: A Model for Determining Long-Term Survival (2006) (48)
Role of neoadjuvant chemotherapy in resectable synchronous colorectal liver metastasis; An international multi‐center data analysis using LiverMetSurvey (2015) (48)
[Liver transplantation with cavoportal or renoportal anastomosis: a solution in cases of diffuse portal thrombosis]. (2002) (48)
Downstaging or downsizing: time for a new staging system in advanced colorectal cancer? (2006) (48)
Tumor Marker Evolution: Comparison with Imaging for Assessment of Response to Chemotherapy in Patients with Colorectal Liver Metastases (2010) (48)
Surgical treatment of hepatocellular carcinoma in cirrhosis: liver resection or transplantation? (1993) (47)
ALPPS for Locally Advanced Intrahepatic Cholangiocarcinoma: Did Aggressive Surgery Lead to the Oncological Benefit? An International Multi-center Study (2020) (47)
Re-resection for colorectal liver metastasis. (1996) (47)
Hepatitis C virus viral recurrence and liver mitochondrial damage after liver transplantation in HIV-HCV co-infected patients. (2005) (47)
Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma (2017) (47)
Chronomodulation of chemotherapy against metastatic colorectal cancer (1995) (46)
Donor factors influencing organ transplant prognosis. (1995) (46)
Parenchymal-sparing hepatectomies (PSH) for bilobar colorectal liver metastases are associated with a lower morbidity and similar oncological results: a propensity score matching analysis. (2016) (46)
Liver transplantation for unresectable hepatocellular carcinoma in normal livers. (2012) (45)
Prognostic value of lymphadenectomy for long-term outcomes in node-negative intrahepatic cholangiocarcinoma: A multicenter study. (2019) (44)
mTOR Inhibition Is Most Beneficial After Liver Transplantation for Hepatocellular Carcinoma in Patients With Active Tumors. (2020) (44)
Impact of tumour differentiation to select patients before liver transplantation for hepatocellular carcinoma (2011) (44)
Hepatic resection after down-staging of unresectable hepatic colorectal metastases. (2003) (44)
Vascular reconstruction combined with liver resection for malignant tumours (2013) (43)
An Ordinal Model to Predict the Risk of Symptomatic Liver Failure in Patients with Cirrhosis undergoing Hepatectomy. (2019) (43)
Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis (2020) (42)
Actual incidence and long-term consequences of posthepatectomy liver failure after hepatectomy for colorectal liver metastases. (2014) (42)
Treatment of irresectable liver tumours by percutaneous cryosurgery (1998) (41)
Choices of Therapeutic Strategies for Colorectal Liver Metastases Among Expert Liver Surgeons: A Throw of the Dice? (2020) (41)
Portal vein arterialization: a salvage procedure for a totally de-arterialized liver. The Paul Brousse Hospital experience. (2014) (41)
Symptomatic and proven de novo amyloid polyneuropathy in familial amyloid polyneuropathy domino liver recipients (2011) (40)
Natural history of portal vein embolization before liver resection: a 23‐year analysis of intention‐to‐treat results (2018) (39)
Resection of Colorectal Liver Metastases with Extrahepatic Disease (2009) (39)
The difficulty in defining extended donor criteria for liver grafts: the Eurotransplant experience (2013) (38)
Surgical resection versus systemic therapy for breast cancer liver metastases: Results of a European case matched comparison. (2018) (38)
Favorable Outcomes of Liver Transplantation from Controlled Circulatory Death Donors Using Normothermic Regional Perfusion Compared to Brain Death Donors (2020) (38)
Is Enhanced One-Stage Hepatectomy a Safe and Feasible Alternative to the Two-Stage Hepatectomy in the Setting of Multiple Bilobar Colorectal Liver Metastases? A Comparative Analysis between Two Pioneering Centers (2018) (38)
Partial portacaval shunt: renaissance of an old concept. (1992) (38)
Transplantation of small donor livers in adult recipients. (1993) (37)
Proposal of a New Comprehensive Notation for Hepatectomy: The "New World" Terminology. (2021) (37)
Vascular invasion and survival after liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry. (2018) (37)
Impact of COVID‐19 on liver transplantation in Europe: alert from an early survey of European Liver and Intestine Transplantation Association and European Liver Transplant Registry (2020) (37)
Chronomodulated irinotecan, oxaliplatin, and leucovorin-modulated 5-Fluorouracil as ambulatory salvage therapy in patients with irinotecan- and oxaliplatin-resistant metastatic colorectal cancer. (2006) (37)
Strategies to treat primary unresectable colorectal liver metastases. (2005) (36)
Liver transplantation for adenomatosis: European experience (2016) (36)
Locoregional treatments before liver transplantation for hepatocellular carcinoma: a study from the European Liver Transplant Registry (2018) (36)
Resection of colorectal liver metastases after second-line chemotherapy: is it worthwhile? A LiverMetSurvey analysis of 6415 patients. (2017) (35)
A Validated Prognostic Multigene Expression Assay for Overall Survival in Resected Colorectal Cancer Liver Metastases (2016) (35)
Intention‐to‐treat analysis of percutaneous endovascular treatment of hepatic artery stenosis after orthotopic liver transplantation (2016) (35)
Minor Hepatectomies: Focusing a Blurred Picture: Analysis of the Outcome of 4471 Open Resections in Patients Without Cirrhosis. (2019) (35)
Prevalence of dyslipidemia in liver transplant recipients. (1992) (35)
Impact of clinically evident portal hypertension on the course of hepatocellular carcinoma in patients listed for liver transplantation (2015) (34)
Evolution of neoadjuvant therapy for extended hepatic metastases—have we reached our (non‐resectable) limit? (2010) (34)
Sex moderates circadian chemotherapy effects on survival of patients with metastatic colorectal cancer: a meta-analysis. (2012) (34)
Combined liver and kidney transplantation in patients with chronic nephritis associated with end-stage liver disease. (1995) (34)
First Long-term Oncologic Results of the ALPPS Procedure in a Large Cohort of Patients With Colorectal Liver Metastases. (2020) (34)
Prognostic Value and Prediction of Extratumoral Microvascular Invasion for Hepatocellular Carcinoma (2019) (33)
Influence of larger graft weight to recipient weight on the post‐liver transplantation course (2013) (33)
Operative Risks of Domino Liver Transplantation for the Familial Amyloid Polyneuropathy Liver Donor and Recipient: A Double Analysis (2011) (33)
Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers (2021) (33)
Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma. (1993) (32)
[Liver transplantation for intrahepatic Rendu-Osler-Weber's disease: the Paul Brousse hospital experience]. (2002) (32)
Spontaneous Splenorenal Shunt in Liver Transplantation: Results of Left Renal Vein Ligation Versus Renoportal Anastomosis (2015) (32)
Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines. (2021) (32)
How to increase the resectability of initially unresectable colorectal liver metastases: A surgical perspective (2019) (32)
Comparison of Complete Pathologic Response and Hepatic Injuries Between Hepatic Arterial Infusion and Systemic Administration of Oxaliplatin in Patients with Colorectal Liver Metastases (2014) (32)
Feasibility, safety and efficacy of two-stage hepatectomy for bilobar liver metastases of colorectal cancer: a LiverMetSurvey analysis. (2017) (32)
Indicating ALPPS for Colorectal Liver Metastases: A Critical Analysis of Patients in the International ALPPS Registry (2018) (32)
Liver transplantation in Europe: is there a room for improvement? (2005) (31)
Accomplishments in 2008 in the management of curable metastatic colorectal cancer. (2009) (31)
Transplantation of three adult patients with one cadaveric graft: Wait or innovate (2000) (30)
Treatment of failed Roux-en-Y hepaticojejunostomy after post-cholecystectomy bile ducts injuries. (2013) (30)
Non‐invasive ICG‐clearance: a useful tool for the management of hepatic artery thrombosis following liver transplantation (2011) (30)
Evolution of liver transplantation for hepatocellular carcinoma. (2003) (30)
Delivery of hepato-pancreato-biliary surgery during the COVID-19 pandemic: an European-African Hepato-Pancreato-Biliary Association (E-AHPBA) cross-sectional survey (2020) (30)
Liver-First Approach for Synchronous Colorectal Metastases: Analysis of 7360 Patients from the LiverMetSurvey Registry (2021) (29)
Survival of children after liver transplantation for hepatocellular carcinoma (2018) (29)
Xenotransplantation: baboons as potential liver donors? Scientific and ethical issues. (1993) (29)
[Evaluation of results of liver transplantation: experience based on a series of 1052 transplantations]. (1995) (29)
Trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades (2018) (29)
Orthotopic liver transplantation with hepatic artery anastomoses. Hemodynamics and response to hemorrhage in conscious rats. (1990) (28)
Reduction of nonresectable liver metastasis from colorectal cancer after oxaliplatin chemotherapy. (1998) (28)
Age greater than 50 years is not a contraindication for liver donation. (1991) (27)
Sex‐dependent least toxic timing of irinotecan combined with chronomodulated chemotherapy for metastatic colorectal cancer: Randomized multicenter EORTC 05011 trial (2020) (27)
Oncosurgery: a new reality in metastatic colorectal carcinoma. (2002) (27)
The importance of visceral metastasectomy in colorectal cancer. (2000) (27)
Management of excluded segmental bile duct leakage following liver resection. (2009) (26)
Arterial Lactate Concentration at the End of Liver Transplantation Is an Early Predictor of Primary Graft Dysfunction. (2019) (26)
Repeat Hepatectomy for Breast Cancer Liver Metastases (2015) (26)
Liver Transplantation for Acute Intermittent Porphyria (2020) (26)
Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases (2016) (26)
A Decision Analysis Model Identifies the Interval of Efficacy for Transarterial Chemoembolization (TACE) in Cirrhotic Patients with Hepatocellular Carcinoma Awaiting Liver Transplantation (2007) (26)
Outcomes of parenchyma‐preserving hepatectomy and right hepatectomy for solitary small colorectal liver metastasis: A LiverMetSurvey study (2017) (26)
Reliability of the MEGX test in the selection of liver grafts. (1991) (25)
Interest of preoperative immunonutrition in liver resection for cancer: study protocol of the PROPILS trial, a multicenter randomized controlled phase IV trial (2014) (25)
Prospective Phase II Trial of Irinotecan, 5-Fluorouracil, and Leucovorin in Combination as Salvage Therapy for Advanced Colorectal Cancer (2001) (25)
Prognostic variables for resection of colorectal cancer hepatic metastases: an evolving paradigm. (2008) (24)
Ringer's lactate vs serum albumin as a flush solution for UW preserved liver grafts: results of a prospective randomized study. (1991) (24)
Predictive Profile-Nomogram for Liver Resection for Breast Cancer Metastases: An Aggressive Approach with Promising Results (2017) (24)
Margin Status is Still an Important Prognostic Factor in Hepatectomies for Colorectal Liver Metastases: A Propensity Score Matching Analysis (2018) (24)
Randomized, phase II study of bevacizumab with mFOLFOX6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: Resectability and safety in OLIVIA. (2013) (23)
Paul Brousse Liver Transplantation: the first 1,500 cases. (2000) (23)
The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without preoperative chemotherapy. (2013) (23)
Liver transplantation from elderly donors. (1993) (23)
A phase I-II trial of five-day continuous intravenous infusion of 5-fluorouracil delivered at circadian rhythm modulated rate in patients with metastatic colorectal cancer. (1995) (22)
A preliminary European Liver and Intestine Transplant Association-European Liver Transplant Registry study on informed recipient consent and extended criteria liver donation. (2013) (22)
Predicting the risk of post-hepatectomy portal hypertension using a digital twin: a clinical proof of concept. (2020) (22)
COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study (2021) (22)
Impact of Surgical Treatment for Recurrence After 2-Stage Hepatectomy for Colorectal Liver Metastases, on Patient Outcome (2017) (22)
A minimally invasive approach to the treatment of stenosis of the portal vein after hepatic transplantation. (1993) (21)
The anterior approach: the right way for right massive hepatectomy. (2001) (21)
Effect of ischemic preconditioning on hepatic tolerance to cold ischemia in the rat (1998) (21)
Loss of epidermal growth factor receptor expression in lymph node and liver metastases of colon carcinoma. (2005) (21)
Evidence of intermetastatic heterogeneity for pathological response and genetic mutations within colorectal liver metastases following preoperative chemotherapy (2016) (21)
Impact of glycogen content of the donor liver in clinical liver transplantation. (1993) (21)
The influence of the glycogen content of the donor liver on subsequent graft function and survival in rat liver transplantation. (1992) (21)
Longterm Survival After Liver Transplantation for Autoimmune Hepatitis: Results From the European Liver Transplant Registry (2020) (21)
Results after nonsurgical local treatment of primary liver malignancies (2000) (20)
Long-term survival and cure model following liver resection for breast cancer metastases (2018) (20)
European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children (2021) (20)
High levels of glycogen in the donor liver improve survival after liver transplantation in rats. (1991) (20)
Equivalent survival in patients with and without steatosis undergoing resection for colorectal liver metastases following pre-operative chemotherapy. (2014) (19)
Surgical Management of Hepatobiliary and Pancreatic Disorders (2003) (19)
Hepatobiliary scintigraphy and kinetic growth rate predict liver failure after ALPPS: a multi-institutional study. (2020) (19)
Limits of the MEGX test in the selection of liver grafts for transplantation. (1993) (18)
Clinical practice guidelines for the management of liver metastases from extrahepatic primary cancers 2021 (2020) (18)
Major Hepatectomy for Colorectal Liver Metastases in Patients Aged Over 80: A Propensity Score Matching Analysis (2016) (18)
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liver metastases initially non-resectable: A phase II randomized Study—Prodige 14 – ACCORD 21 (METHEP-2), a unicancer GI trial. (2016) (18)
Extreme large‐for‐size syndrome after adult liver transplantation: A model for predicting a potentially lethal complication (2017) (18)
Is primary resection and salvage transplantation for hepatocellular carcinoma a reasonable strategy? (2005) (18)
Potential of a cure in patients with colorectal liver metastases and concomitant extrahepatic disease (2017) (18)
Systematic computer tomographic scans 7 days after liver transplantation surgery can lower rates of repeat-transplantation due to arterial complications. (2014) (18)
Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatic resection or liver transplantation. (2019) (18)
EFFECTS OF ISCHEMIC PRECONDITIONING OF THE CADAVERIC LIVER ON THE GRAFT’S PRESERVATION AND FUNCTION: THE YING AND THE YANG (2004) (17)
Lipid and apolipoprotein changes after orthotopic liver transplantation for end-stage liver diseases. (1992) (17)
Repeat liver retransplantation: rationale and outcomes (2016) (17)
Liver Transplantation for Hepatic Trauma: A Study From the European Liver Transplant Registry (2016) (17)
Impact of peri-operative bevacizumab on survival in patients with resected colorectal liver metastases: an analysis of the LiverMetSurvey. (2014) (17)
Indocyanine green fluorescence imaging to evaluate graft perfusion during liver transplantation. (2019) (17)
Beneficial effects of Eurocollins as aortic flush for the procurement of human livers. (1996) (17)
Epiploic flap: a new site for islet implantation in man. (1990) (17)
The role of cetuximab in converting initially unresectable colorectal cancer liver metastases for resection. (2017) (17)
A new “no-touch” technique for the laparoscopic treatment of gastric stromal tumors (2002) (16)
MDR1 polymorphism role in patients treated with cetuximab and irinotecan in irinotecan refractory colorectal cancer (2010) (16)
Stratification of Major Hepatectomies According to Their Outcome: Analysis of 2212 Consecutive Open Resections in Patients Without Cirrhosis. (2020) (16)
Pharmacogenetic determinants of outcomes on triplet hepatic artery infusion and intravenous cetuximab for liver metastases from colorectal cancer (European trial OPTILIV, NCT00852228) (2017) (16)
Chronomodulation of chemotherapy against metastatic colorectal cancer. International Organization for Cancer Chronotherapy. (1995) (16)
Liver Transplantation for Hepatocellular Carcinoma in Cirrhosis (1996) (16)
Successful Long‐term Outcome of ABO‐incompatible Liver Transplantation Using Antigen‐specific Immunoadsorption Columns (2010) (15)
Liver transplantation in elderly patients: what do we know at the beginning of 2020? (2020) (15)
Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry (2018) (15)
Central Hepatectomy versus Extended Hepatectomy for Malignant Tumors: A Propensity Score Analysis of Postoperative Complications (2016) (15)
Postoperative Infectious Complications Impact Long-Term Survival in Patients Who Underwent Hepatectomies for Colorectal Liver Metastases: a Propensity Score Matching Analysis (2018) (15)
Is Cure Possible After Sequential Resection of Hepatic and Pulmonary Metastases From Colorectal Cancer? (2017) (15)
Exploring Gene Expression Signatures for Predicting Disease Free Survival after Resection of Colorectal Cancer Liver Metastases (2012) (15)
Laparoscopic major hepatectomy for hepatocellular carcinoma in elderly patients: a multicentric propensity score‑based analysis (2020) (14)
Sorafenib vs surgical resection for hepatocellular carcinoma with macrovascular invasion: A propensity score analysis (2017) (14)
Intraoperative hypotension during liver transplant surgery is associated with postoperative acute kidney injury: a historical cohort study (2021) (14)
Towards a better liver transplant allocation system (2007) (14)
Influence of donor and recipient gender on liver transplantation outcomes in Europe (2016) (14)
Short- and long-term results of extended left hepatectomy for colorectal metastases. (2011) (14)
The influence of the temperature of storage on survival and ultrastructure of transplanted UW-preserved rat liver grafts. (1993) (14)
Portal stenting for hepatocellular carcinoma extending into the portal vein in cirrhotic patients (2013) (14)
Sequential transcatheter arterial chemoembolization and portal vein embolization versus portal vein embolization alone before major hepatectomy for patients with large hepatocellular carcinoma: An intent-to-treat analysis. (2019) (14)
Long-term results of combined kidney and liver transplantation at one center. (1997) (14)
Reply to Letter Regarding “Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long‐Term Graft Outcome Study From the European Liver Transplant Registry” (2015) (14)
Liver Venous Deprivation or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy? (2021) (13)
Impact of the type and modalities of preoperative chemotherapy on the outcome of liver resection for colorectal metastases. (2011) (13)
LiverMetSurvey: Analysis of clinicopathologic factors associated with the efficacy of preoperative chemotherapy in 2,122 patients with colorectal liver metastases. (2006) (13)
Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation. (2017) (13)
Adult liver transplantation: the Paul Brousse experience. (2007) (13)
Evaluation of a micro-spectrometer for the real-time assessment of liver graft with mild-to-moderate macrosteatosis: A proof of concept study. (2019) (13)
Hematobilia resulting from heterotopic stomach in the gallbladder neck. (1989) (13)
The role of biological agents in the resection of colorectal liver metastases. (2012) (13)
Efficacy and safety of chronomodulated irinotecan, oxaliplatin, 5‐fluorouracil and leucovorin combination as first‐ or second‐line treatment against metastatic colorectal cancer: Results from the International EORTC 05011 Trial (2020) (13)
[Adult to adult living-related liver transplantation. The Paul-Brousse Hospital preliminary experience]. (2001) (12)
[Indications and results of liver transplantation in the treatment of hepatocellular carcinoma in cirrhosis]. (1998) (12)
Liver Resection for Early Hepatocellular Carcinoma: Preoperative Predictors of Non Transplantable Recurrence and Implications for Treatment Allocation. (2020) (12)
Predictive Factors for Survival in Children Receiving Liver Transplants for Wilson’s Disease: A Cohort Study Using European Liver Transplant Registry Data (2018) (12)
Lidocaine metabolite formation in the liver donor as a predictive test for the safe and efficient introduction of cyclosporine in the recipient. (1993) (12)
Ideal Surgical Margin to Prevent Early Recurrence After Hepatic Resection for Hepatocellular Carcinoma (2021) (12)
Comparative evaluation of Euro-Collins, UW solution, and UW solution without hydroxyethyl starch in orthotopic liver transplantation in the rat. (1990) (12)
13 Liver transplantation of HIV-HCV and HIV-HBV coinfected patients: A large experience in a single centre (2006) (12)
Risk factors of preservation injury and prognostic value of reperfusion biopsy in outcome of liver transplantation. (1996) (12)
Evaluation of HTK Preservation Solutions in Liver Transplantation: A Long‐Term Propensity‐Based Analysis of Outcome From the European Liver Transplant Registry (2017) (11)
Outcomes of Rehepatectomy for Colorectal Liver Metastases: A Contemporary Multi-Institutional Analysis from the French Surgical Association Database (2016) (11)
Outcomes associated with amphotericin B lipid complex (ABLC) prophylaxis in high-risk liver transplant patients. (2013) (11)
What is the Prognostic Value of a Discordant Radiologic and Pathologic Response in Patients Undergoing Resection of Colorectal Liver Metastases After Preoperative Chemotherapy? (2020) (11)
Induction chemotherapy (CT) with FOLFIRINOX or FOLFOX/FOLFIRI, plus cetuximab (CET) or bevacizumab (BEV) (by RAS status), in patients (pts) with primarily unresectable colorectal liver metastases (CRLM): Results of the randomized UNICANCER PRODIGE 14-ACCORD 21 (METHEP-2) trial. (2018) (11)
Quality of life 10 years after liver transplantation: The impact of graft histology (2016) (11)
Temporal Trends and Outcomes in Liver Transplantation for Recipients With HIV Infection in Europe and United States. (2020) (11)
Severe hepatic sinusoidal obstruction and oxaliplatin-based chemotherapy in patients with metastatic colorectal cancer: a real entity? (2005) (11)
Importance of conserving middle hepatic vein distal branches for homogeneous regeneration of the left liver after right hepatectomy. (2012) (10)
Accomplishments in 2007 in the management of curable metastatic colorectal cancer. (2008) (10)
Indocyanine Green Retention Rates at 15 min Predicted Hepatic Decompensation in a Western Population (2018) (10)
Current surgical strategies for the treatment of colorectal cancer liver metastases (2004) (10)
The Postresection Alpha-Fetoprotein in Cirrhotic Patients with Hepatocellular Carcinoma. An Independent Predictor of Outcome (2014) (10)
Oxaliplatin Plus Irinotecan and FU-FOL Combination and Pharmacokinetic Analysis in Advanced Colorectal Cancer Patients (2004) (10)
Left-liver Adult-to-Adult Living Donor Liver Transplantation: Can It Be Improved? A Retrospective Multicenter European Study (2018) (10)
Hepatocellular carcinoma: from ethanol injection to liver transplantation. (1999) (10)
LIVER TRANSPLANTATION FOR RECURRENCE AFTER RESECTION OF SOLITARY HEPATOCELLULAR CARCINOMA (1999) (10)
Liver Venous Deprivation (LVD) or Associating Liver Partition and Portal Vein Ligation for Staged Hepatectomy (ALPPS)?: A Retrospective Multicentric Study. (2021) (9)
[52] LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA: VALIDATION OF A NEW PROGNOSTIC SCORE PREDICTING DISEASE-FREE SURVIVAL (2007) (9)
Management of the Open Abdomen after Liver Transplantation (2017) (9)
Characteristics, Trends, and Outcomes of Liver Transplantation for Primary Sclerosing Cholangitis in Female Versus Male Patients: An Analysis From the European Liver Transplant Registry (2020) (9)
Influence of high aminotransferase levels on rejection in liver transplantation. (1994) (8)
Experience in one center of combined kidney and liver transplantation in 22 patients: incidence of graft rejection and long-term graft outcome. (1997) (8)
Impact of preservation-induced liver injury on the risk of rejection of rat and human liver grafts. (1995) (8)
Protective effect of alanine against graft failure of transplanted livers from fasted donor rats. (1995) (8)
[Induction chemotherapy and surgery of colorectal liver metastases]. (2006) (8)
Prediction of the Total Liver Weight using anthropological clinical parameters: does complexity result in better accuracy? (2017) (8)
139 Etiology, outcome and early causes of death in 427 patients with acute liver failure (ALF): A 20 year single-center experience (2006) (8)
[Auxiliary partial orthotopic liver transplantation using small grafts. A way to avoid small-for-size syndrome?]. (2005) (8)
Improved survival in liver transplant patients receiving prolonged-release tacrolimus-based immunosuppression in the European Liver Transplant Registry (ELTR): an extension study. (2019) (7)
O-0025RANDOMISED, PHASE 2 STUDY (OLIVIA) OF BEVACIZUMAB PLUS MFOLFOX6 OR FOLFOXIRI IN PATIENTS WITH INITIALLY UNRESECTABLE COLORECTAL CANCER LIVER METASTASES (2013) (7)
Phase I‐II Study of Irinotecan in Combination With Mitomycin C in Patients With Advanced Gastrointestinal Cancer (2001) (7)
Meta-analysis of gender effect for first-line chronomodulated 5-fluorouracil-leucovorin-oxaliplatin (ChronoFLO) compared with FOLFOX or constant infusion (conventional delivery, CONV) against metastatic colorectal cancer (MCC) in three international controlled phase III randomized trials (RT). (2009) (7)
Long‐term outcome after living donor liver transplantation compared to donation after brain death in autoimmune liver diseases: Experience from the European Liver Transplant Registry (2021) (7)
106 LONG TERM OUTCOME OF PATIENTS TRANSPLANTED FOR AUTOIMMUNE HEPATITIS—ANALYSIS OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (2008) (7)
Management of disappearing colorectal liver metastases: an international survey. (2020) (7)
Recurrence of primary sclerosing cholangitis after liver transplantation – analysing the European Liver Transplant Registry and beyond (2021) (7)
Response to cetuximab and gemcitabine-oxaliplatin in an advanced case of intrahepatic cholangiocarcinoma. (2006) (7)
Suitability of livers for transplantation when treated by normothermic machine perfusion (2018) (7)
Indocyanine Green Fluorescence Imaging to Predict Graft Survival After Orthotopic Liver Transplantation: A Pilot Study (2020) (7)
Early tumour response as a survival predictor in previously- treated patients receiving triplet hepatic artery infusion and intravenous cetuximab for unresectable liver metastases from wild-type KRAS colorectal cancer. (2016) (7)
Multimodality Imaging of Cardiac Transthyretin Amyloidosis 16 Years After a Domino Liver Transplantation (2016) (7)
Definition and Prospective Assessment of Functional Recovery After Liver Transplantation: A New Objective Consensus‐Based Metric for Safe Discharge (2020) (7)
Living Donor Liver Transplantation: a European Liver Transplant Registry (eltr) Report On 2634 Cases (2009) (6)
Gastrointestinal tumors, non-colorectal (2012) (6)
Ischemic Cholangiopathy Following Transcatheter Arterial Chemoembolization for Recurrent Hepatocellular Carcinoma After Hepatectomy: an Underestimated and Devastating Complication (2019) (6)
Serial volumetric assessment of large for size liver grafts after whole cadaveric liver transplant in adults: do large liver grafts shrink in size? (2016) (6)
[Training of residents in surgery: need for contractual agreement]. (2002) (6)
Temporal Trends and Outcomes in Liver Transplantation for Recipients with Human Immunodeficiency Virus Infection in Europe and United States. (2019) (6)
Variation in complications and mortality following ALPPS at early-adopting centers. (2020) (6)
Cetuximab plus gemcitabine/oxaliplatin (GEMOX) for patients with unresectable/recurrent intrahepatic cholangiocarcinoma refractory to GEMOX. (2006) (6)
Mortality after Transplantation for Hepatocellular Carcinoma: A Study from the European Liver Transplant Registry (2020) (6)
Postoperative liver function recovery after hepatic resection for colorectal metastases previously treated with bevacizumab. (2009) (6)
Effect of storage temperature on early graft function following liver transplantation. (1992) (6)
Number of hepatocellular carcinoma nodules in patients listed for liver transplantation within alpha‐fetoprotein score: a new prognostic risk factor (2021) (6)
Totally intra-corporeal Pringle maneuver during laparoscopic liver resection. (2017) (6)
Radiofrequency ablation vs surgical resection in elderly patients with hepatocellular carcinoma in Milan criteria (2021) (6)
[Multistage liver resections in colorectal liver metastases. The Paul Brousse concept]. (2001) (6)
Prospective phase II trial of iriontecan, 5-fluorouracil, and leucovorin in combination as salvage therapy for advanced colorectal cancer. (2001) (5)
COVID‐19 heath crisis: less colorectal resections and yet no more peritonitis or bowel obstruction as a collateral effect? (2020) (5)
Improved first-line chemotherapy: a better chance for surgery? (2010) (5)
Assessment of the results of liver transplantation and definition of criteria for the evaluation of transplant centers. (1997) (5)
Medical community preferences concerning adult living related donor liver transplantation. (2006) (5)
The Paul Brousse liver transplant series 1989 to 1992: new trends in the last four years. (1992) (5)
Liver transplantation for iatrogenic bile duct injury during cholecystectomy: a French retrospective multicenter study. (2021) (5)
Improving the Safety of ALPPS Procedure: The Optimal Compromise Between Dropout and Mortality Risk. Comment on Schadde E et al Prediction of Mortality After ALPPS Stage-1: An Analysis of 320 Patients From the International ALPPS Registry. Ann Surg. 2015;262: 780-786. (2017) (5)
[Liver transplantation in the treatment strategy of portal hypertension]. (1995) (5)
Spleen volumetry and liver transient elastography: Predictors of persistent posthepatectomy decompensation in patients with hepatocellular carcinoma. (2020) (5)
Debulking surgery for colorectal liver metastases: Foolish or chance? (2020) (5)
Resection of non resectable liver metastases after chemotherapy: Prognostic factors and long term results. (2004) (5)
Current results of living-related liver transplantation (LRLT) in Europe. Report from the European Liver Transplantation Registry (ELTR) (2002) (5)
[32] MODERATE EXPANSION OF MILAN CRITERIA FOR TRANSPLANTATION FOR HCC DOES NOT IMPACT SURVIVAL NOR RECURRENCE RATES (2007) (5)
Locoregional surgical and interventional therapies for advanced colorectal liver metastasis: expert consensus statement. (2013) (5)
Revisiting the Surgical Management of Giant Hepatic Hemangiomas: Enucleation Versus Anatomical Resection? (2020) (4)
High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients (2021) (4)
Is Routine Intraoperative Contrast-Enhanced Ultrasonography Useful During Whole Liver Transplantation? (2018) (4)
Acute cyclosporine toxicity after liver transplantation is predicted by the lidocaine monoethylglycinexylidide test in the donor. (1997) (4)
Predictors of unresectability after portal vein embolization for centrally located cholangiocarcinoma. (2020) (4)
HCC recurrence in HCV‐infected patients after liver transplantation: SiLVER Study reveals benefits of sirolimus in combination with CNIs – a post‐hoc analysis (2020) (4)
Personalized Preoperative Nomograms Predicting Postoperative Risks after Resection of Perihilar Cholangiocarcinoma (2020) (4)
Prognosis of Children Undergoing Liver Transplantation: A 30-Year European Study. (2022) (4)
Incorporation of Donor Risk Into Liver Allocation Algorithms (2013) (4)
Early Versus Late Hepatocellular Carcinoma Recurrence After Transplantation: Predictive Factors, Patterns, and Long-term Outcome (2020) (4)
Four-year survival in patients (pts) undergoing liver surgery after neoadjuvant triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) for previously treated and unresectable liver metastases from kras wt colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228). (2014) (4)
124 HCV viral recurrence and liver mitochondrial damage after liver transplantation (LT) in HIV-HCV coinfected patients (2004) (4)
Diffuse Versus Localized Caroli Disease: A Comparative MRCP Study. (2021) (4)
Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial. (2017) (4)
Liver transplantation for hepatocellular carcinoma in non-cirrhotic livers. (2007) (4)
Influence of 4 preservation solutions on ICU stay, graft and patient survival following liver transplantation. (2020) (4)
[Resection of liver metastases in breast cancer]. (2015) (4)
Oncosurgical strategies for metastatic liver cancer (2011) (4)
Impact of body mass index on hepatocellular carcinoma recurrence after liver transplantation through long-term follow-up. (2020) (3)
[Alcoholic liver cirrhosis. Treatment of hepatocellular carcinoma]. (2001) (3)
Liver growth prediction in ALPPS – A multicenter analysis from the international ALPPS registry (2022) (3)
Nineteen donor deaths following living donor liver transplantation: review of the worldwide experience (2006) (3)
Repeat hepatectomy for primary liver cancer (2001) (3)
Plasma lipids and apolipoproteins in end-stage liver disease. (1990) (3)
A Systematic Review and Meta‐Analysis of Cold In Situ Perfusion and Preservation of the Hepatic Allograft: Working Toward a Unified Approach (2018) (3)
LBA-001Efficacy, tolerability and impact on quality of life of selective internal radiation therapy (with yttrium-90 resin microspheres) or sorafenib in patients with locally advanced hepatocellular carcinoma: The SARAH trial. (2017) (3)
Xenogeneic liver transplantation: its influence on secondary allogeneic graft rejection. (1990) (3)
Implications of chronobiology for 5-fluorouracil (5-FU) efficacy. (1993) (3)
Frequencyand outcomes of liver transplantation for nonalcoholic steatohepatitis in Europe (2018) (3)
Laparoscopic surgery versus radiofrequency ablation for the treatment of single hepatocellular carcinoma ≤3 cm in the elderly: a propensity score matching analysis. (2021) (3)
The Liver Retransplantation Risk Score: a prognostic model for survival after adult liver retransplantation (2021) (3)
Two-Stage Liver Surgery (2017) (3)
Results of percutaneous manoeuvres in biliary disease: The Paul Brousse experience (2011) (3)
Extended Hepatectomy for Primary and Metastatic Liver Lesions (2009) (2)
Liver re-transplantation: internal validation of a predictive mathematical model of survival. (2012) (2)
VALIDATION AND REFINEMENT OF A SURVIVAL MODEL FOR LIVER RETRANSPLANTATION (1999) (2)
PD-0029CHEMOTHERAPY PLUS CETUXIMAB AS CONVERSION TREATMENT FOR PATIENTS WITH INITIALLY UNRESECTABLE LIVER METASTASES FROM COLORECTAL CANCER (2013) (2)
[Vascular clamping of the liver. Indications and limits]. (1997) (2)
191 EVOLUTION AFTER LISTING AND RESULTS OF LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA IN HIV/HCV AND HIV/HBV COINFECTED PATIENTS (2008) (2)
Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation? (2022) (2)
Comments on: "ALPPS Improves Survival Compared With TSH in Patients Affected of CRLM: Survival Analysis From the Randomized Controlled Trial LIGRO" Survival Benefit of ALPPS versus TSH: a Proof of Concept or a Concept to be Proved? (2020) (2)
Role of laparoscopic approach in colorectal liver metastasis. An international multi-center data analysis using LiverMetSurvey (2016) (2)
Use of Pharmacologic Agents for Modulation of Ischaemia-Reperfusion Injury after Hepatectomy: A Questionnaire Study of the LiverMetSurvey International Registry of Hepatic Surgery Units (2014) (2)
Urinary thromboxane B2 as an indicator of acute rejection in human liver transplantation (1996) (2)
Clinical presentation and outcome of Wilson’s disease patients in a monocentric cohort of liver reference center (2018) (2)
What did the European Liver Transplant Registry bring to liver transplantation? (2020) (2)
LIVER TRANSPLANTATION IN ISOLATED POLYCYSTIC LIVER DISEASE (2009) (2)
Hormone receptor status as a prognostic factor in breast cancer patients with hepatic metastases treated by liver resection. (2007) (2)
Liver transplantation with cavoportal or renoportal anastomosis (2008) (2)
Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection (2019) (2)
CHARACTERISTICS ASSOCIATED WITH OUTCOME AFTER LIVER-TRANSPLANTATION AND VALIDATION OF THE DONOR-RISK-INDEX IN EUROTRANSPLANT (2010) (2)
Liver transplantation for colorectal liver metastasis: aiming for a cure or a palliation? (2021) (2)
The Impact of Time Interval between Hepatic Resection and Liver Transplantation on Clinical Outcome in Patients with Hepatocellular Carcinoma (2021) (2)
Resection after chemotherapy (CT) with irinotecan (CPT) for initially unresectable liver metastasis (LM) from colorectal cancer (CRC) (2004) (2)
De novo hepatocellular carcinoma in a non‐cirrhotic allograft 27 years after liver transplantation: A case report (2020) (2)
Late hepaticartery thrombosis after liver transplantation: which strategy? A single‐center retrospective study (2019) (2)
Adult to adult living-related liver transplantation (2008) (2)
Survival after liver transplantation (2001) (1)
The percentage of patients with HCV infection in need of a liver transplant is rapidly declining while their survival after transplantation is improving: A study based on European liver transplant registry (2018) (1)
Time trends in liver transplantation for primary biliary cholangitis in Europe over the past three decades (2018) (1)
The Paul Brousse liver transplant series 1984-1988. (1988) (1)
Chronomodulated irinotecan (I), fluorouracil (F), leucovorin (L), and oxaliplatin (O) (chrono IFLO) as salvage therapy in oxaliplatin- and irinotecan-resistant advanced colorectal cancer (ACRC): Treatment results and toxicity profile. (2004) (1)
Early‐ and long‐term outcomes of liver transplantation with rescue allocation grafts (2020) (1)
Adjuvant Gemcitabine-Oxaliplatin (GEMOX) after Curative Surgery in High-risk Patients with Cholangiocarcinoma (2009) (1)
EFFICACY AND LONG-TERM OUTCOME OF AMPHOTERICIN B LIPID COMPLEX (ABLC) PROPHYLAXIS IN HIGH RISK LIVER TRANSPLANT RECIPIENTS IN THE CURRENT PRACTICE: 2175 (2010) (1)
Optimizing FOLFIRINOX tolerability in patients with colorectal cancer through dosing irinotecan in the morning for men and in the afternoon for women. (2020) (1)
Long-term survival of patients with unresectable metastatic colorectal cancer treated with chronotherapy (1993) (1)
Principles of Hepatic Surgery (2016) (1)
Chronomodulated hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil (5-FU), and oxaliplatin (l-OHP) plus intravenous (iv) cetuximab (Cet) (Chrono-Optiliv) in patients with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after treatment failure (European Phase II trial N (2013) (1)
Evolution of liver transplantations in Europe (2010) (1)
Liver Retransplantation Associated With Kidney Transplantation for End-stage Liver Graft Disease and Renal Insufficiency: A Morbid Procedure on a Unique Subgroup of Patients (2019) (1)
HEPATIC EPITHELIOID HEMANGIO-ENDOTHELIOMA AND ADULT LIVER TRANSPLANTATION: PROPOSAL FOR A PROGNOSTIC SCORE BASED ON THE ANALYSIS OF THE ELTR-ELITA REGISTRY. (2016) (1)
Surrogate Markers of Overall Survival in Metastatic Colorectal Cancer: An Evolving Challenge Still More Complex with Repeat Surgery (2014) (1)
[Chemotherapy and surgery in the treatment of liver metastasis of colorectal cancer: a sacred union...]. (2003) (1)
Liver Transplantation in Severe Neurological Forms of Wilson Disease; The French Experience (2016) (1)
Impact of Preoperative Chemotherapy Features on Patient Outcomes after Hepatectomy for Initially Unresectable Colorectal Cancer Liver Metastases: A LiverMetSurvey Analysis (2022) (1)
Oncological benefit of parenchyma-preserving hepatectomy for colorectal liver metastasis. (2016) (1)
Cetuximab reversal of resistance to chronomodulated chemotherapy in heavily-pretreated patients with metastatic colorectal cancer (MCC) without amplification of epidermal growth factor receptor (EGFR) gene. (2006) (1)
The Present Day Usage of Nonselective Shunts (1991) (1)
Controversies in the Management of Liver Metastases (2009) (1)
A Model to Predict Significant Macrosteatosis in Hepatic Grafts (2019) (1)
Long-Term Results of Transplantation for Hepatocellular Carcinoma With or Without Cirrhosis: 15 Years’-Experience at Paul Brousse Hospital (2002) (1)
ORTHOTOPIC LIVER TRANSPLANTATION WITH HEPATIC ARTERY ANASTOMOSES (1990) (1)
Liver transplantation for intrahepatic recurrence of hepatocellular carcinoma in non-cirrhotic livers after partial liver resection (2007) (1)
Liver transplantation in HIV-HCV coinfected patients. New indication and preliminary experience (2002) (1)
Liver resection for breast cancer metastases (2016) (1)
Transplantation hépatique de l'adulte à partir de donneur vivant (2008) (1)
Liver transplantation (LT) for hereditary hemorrhagic telangiectasia (HHT): Report of the European liver transplant registry (ELTR) (2007) (1)
[Increased long-term permeability of transjugular intrahepatic portosystemic shunt (TIPS) in 218 cirrhotic patients, with strict monitoring]. (2004) (1)
Non-Colorectal Non-Neuroendocrine Liver Metastases (2016) (1)
Neoadjuvant Treatment for Liver Metastases of Colorectal Cancer (2007) (1)
Primary tumor location as a prognostic implication in patients undergoing resection for colorectal liver metastasis: A propensity score-matched analysis. (2018) (1)
[Resection of liver metastasis of colorectal origin following chemotherapy with irinotecan]. (2004) (1)
Is R2 resection a valuable salvage treatment for colorectal liver metastases (2015) (1)
1004 Resection of unresectable hepatic metastases from colorectal cancer with neoadjuvant chronotherapy (1995) (1)
Initial piggyback technique facilitates late liver retransplantation – a retrospective monocentric study (2021) (1)
Heterogeneity of Bile Duct Management in the Development of Ischemic Cholangiopathy After Liver Transplantation: Results of a European Liver and Intestine Transplant Association Survey. (2019) (1)
Liver allocation for emergency patients in France: needs and limits of a high urgency priority. (1995) (1)
Selective hepatic vascular exclusion versus Pringle manoeuvre in liver resection for tumours encroaching on major hepatic veins (Br J Surg 2012; 99: 973–977) (2012) (1)
459 ANALYSE OF PREDICTIVE FACTORS OF MORTALITY OF HIV/HCV INFECTED PATIENTS ON THE WAITING LIST OF LIVER TRANSPLANTATION (2009) (1)
[36] EVOLUTION OF AETIOLOGY AND OUTCOME IN THE LAST 20 YEARS IN 500 PATIENTS WITH ACUTE LIVER FAILURE. FACTORS PREDICTIVE OF SURVIVAL AND OF NEUROLOGICAL SEQUELLAE (2007) (1)
[Surgery of liver metastases of colorectal carcinoma]. (1998) (1)
Major hepatectomy for intrahepatic cholangiocarcinoma or colorectal liver metastases. Are we talking about the same story? (2019) (1)
41 resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver-size does matter. (2011) (1)
Resection after chemotherapy (CT) with irinotecan (CPT) for initially unresectable liver metastasis (LM) from colorectal cancer (CRC). (2004) (1)
221 OUTCOME OF CIRRHOTIC PATIENTS ADMITTED TO THE LIVER ICU AND PREDICTIVE FACTORS OF MORTALITY: RESULTS OF A RECENT COHORT OF 308 PATIENTS (2009) (1)
[Value of percutaneous ethanol injection in the treatment of hepatocellular carcinoma in a cirrhotic liver]. (1998) (1)
The prognostic impact of primary tumor location in patients undergoing resection for colorectal liver metastasis: A propensity score-matched analysis. (2017) (1)
Recurrence of primary sclerosing cholangitis is associated with lower survival after liver transplantation: an analysis of the European liver transplant registry data base (2017) (1)
Rare genetic heterogeneity within single tumor discovered for the first time in colorectal liver metastases after liver resection (2018) (1)
Final results of first European phase II trial of intravenous cetuximab (Cet) and hepatic artery infusion of irinotecan, 5-fluorouracil, and oxaliplatin in patients (pts) with unresectable liver metastases from wt KRAS colorectal cancer (LM-CRC) after systemic treatment failure (OPTILIV, NCT00852228 (2013) (1)
Subject Index Vol. 25, 2008 (2009) (0)
HPB International Correspondence (1995) (0)
European ELITA ELTR multicenter survey on the management of bile duct during liver procurement, preservation and transplantation (2015) (0)
Are British patients with colorectal liver metastases (CRLM) offered the same opportunity for neoadjuvant chemotherapy (CTX) and potentially curative hepatectomy (HPX) as their European counterparts (2007) (0)
Two-stage hepatectomy for extensive colorectal liver metastases: How to predict the failure to complete both sequential procedures? (2015) (0)
Evidence for resection of colorectal liver metastases (2006) (0)
Factors associated with tumor recurrence after liver transplantation for hepatocellular carcinoma: prospective cohort on 371 patients (2017) (0)
HEPATIC ANGIOSARCOMA (HAS): THE (LAST) ABSOLUTE CONTRA-INDICATION TO LIVER TRANSPLANTATION (LT) REPORT OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR).: 825 (2008) (0)
Reply (2011) (0)
Improvement of Survival by Surgery in the Treatment of Hepatocellular Carcinoma: Evidence or Non-evidenced-based? (2004) (0)
DONATION AFTER CARDIAC DEATH IN LIVER TRANSPLANTATION: A CALCULATED RISK (2010) (0)
Long-term results of resection following downstaging of initially unresectable colorectal metastases (2006) (0)
Feasibility of neoadjuvant transarterial chemoembolization (TACE) using irinotecan beads (DEBIRI) before hepatectomy (HPX) for easily resectable colorectal liver metastases (RCLM): A phase II study. (2010) (0)
Outcome of 1128 proposals for liver donation from brain-dead patients: a 1-year prospective study in Paris centers. (1993) (0)
Impact of the type and modalities of preoperative chemotherapy on the outcome of liver resection for colorectal liver metastases: A LiverMetSurvey study. (2018) (0)
Multimodality treatment of liver metastases from colorectal cancer (2004) (0)
THE PLACE OF LIVER TRANSPLANTATION IN THE TREATMENT OF HEPATIC EPITHELOID HAEMANGIOENDOTHELIOMA: REPORT OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (ELTR): 620 (2008) (0)
Faisabilité, sécurité et efficacité des hépatectomies en deux temps pour métastases hépatiques bilobaires de cancer colorectal : une analyse du registre Livermetsurvey (2017) (0)
FRI-02 Liver metastases from melanoma (2013) (0)
protocolA prospective randomised , open-labeled , trial comparing sirolimus-containing versus mTOR-inhibitor-free immunosuppression in patients undergoing liver transplantation for hepatocellular carcinoma (2010) (0)
209 SYSTEMATIC CT-SCAN ON POST-OPERATIVE DAY 7 AFTER LIVER TRANSPLANTATION DECREASES THE RATE OF RETRANSPLANTATION FOR ARTERIAL COMPLICATIONS (2012) (0)
Laparoscopic Radical Antegrade Modular Pancreatosplenectomy (RAMPS) Technique: Toward the Standardization of the Technique (With Video) (2020) (0)
Pharmacokinetic-pharmacodynamic analysis of hepatic artery infusion of three-drug chronomodulated chemotherapy and intravenous cetuximab in patients with liver metastases from colorectal cancer registered in OPTILIV, a European multicenter phase II trial. (2011) (0)
Accidental transplantation of hepatic graft with incidental T2 gallbladder carcinoma: a report of 3 cases (2020) (0)
ISY-1-3 Onco-surgical treatment of colorectal liver metastases : The need of multidisciplinary approach(ISY-1 International Symposium 1 Treatment strategies for hepatic metastasis of colorectal cancer : Surgical limitation and an appropriate timing of surgical resection after down-staging chemothera (2012) (0)
SAT-492-Associating spleen volume and liver stiffness measurements improves prediction of persistent post-hepatectomy decompensation after resection of hepatocellular carcinoma (2019) (0)
[New surgical strategies for liver metastasis of colorectal cancer: report of 3 cases]. (2003) (0)
Vitamin K epoxide reductase complex subunit 1 (VKORC1): A pharmacogenomic predictor of response and survival in patients (pts) on triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-Cet) for initially unresectable liver metastases from colorectal cancer (uLM-CRC) (EU trial OPTILIV). (2017) (0)
A single arm phase II study of neoadjuvant transarterial regional therapy (TACE) using preloaded Irinotecan Beads in patients with resectable colorectal liver metastases (CRLM). (2015) (0)
Liver splitting for two adult patients (2000) (0)
[Management of colorectal cancer and its metastases to the liver]. (2008) (0)
[37] OUTCOME OF PATIENTS TRANSPLANTED FOR PRIMARY SCLEROSING CHOLANGITIS - ANALYSIS OF THE EUROPEAN LIVER TRANSPLANT REGISTRY (2007) (0)
Compared Efficacy of Preservation Solutions in Liver Transplantation: A Study From the European Liver Transplant Registry.: Abstract# D2672 (2014) (0)
Changes of indications for liver transplantation in the era of direct acting antiviral therapy in Europe (2018) (0)
EFFECTS OF ISCHEMIC PRECONDITIONING OF THE GRAFT IN ADULT LIVING RELATED RIGHT LIVER TRANSPLANTATION: 1690 (2010) (0)
Reply to letter: "resection or transplantation for early hepatocellular carcinoma in a cirrhotic liver: does size define the best oncological strategy?". (2015) (0)
15-year Evolution of Liver Transplantation in Europe. (2008) (0)
Efficacy and safety of chronomodulated hepatic arterial infusion (chronoHAI) of irinotecan (I), oxaliplatin (0) and fluorouracil (F) as salvage treatment for patients (pts) with heavily pretreated liver-predominant metastatic colorectal cancer (MCC). (2015) (0)
158 Donor age and graft histology ten years after liver transplantation (2004) (0)
Analysis of risk factors of early recurrence and ideal surgical margin for hepatocellular carcinoma. (2017) (0)
Colorectal liver metastases with concomitant extrahepatic disease: Is there a hope of cure? (2016) (0)
Liver Splitting for Two Adult Patients and Domino Liver Transplantation: The Paul Brousse Experience (2002) (0)
RISK ASSESSMENT OF LIVER DONATION FOR PATIENTS WITH FAMILIAL AMYLOID POLYNEUROPATHY IN DOMINO LIVER TRANSPLANTATION: 100 CASES FROM A SINGLE CENTER: 1722 (2010) (0)
Comparative analysis of outcomes after liver resection and liver transplantation for early stages hepatocellular carcinoma in HIV-infected patients. An intention-to-treat analysis. (2019) (0)
30 Liver transplantation for cystic fibrosis-related liver disease (2003) (0)
Sequential liver and lung resection for colorectal cancer metastases: In which patients should surgery be proposed? (2015) (0)
493 RESULTS OF LIVER RETRANSPLANTATION IN A MONOCENTRIC COHORT OF HCV INFECTED PATIENTS (2010) (0)
Quality control of the European Liver Transplant Registry (ELTR). Report of the Living Donor Liver Transplantation (LDLT) audit (2008) (0)
[Fifteen years of liver transplantation in Europe]. (2007) (0)
CO.13 Quinze annes dvolution des rsultats de la transplantation hpatique en Europe (2009) (0)
A simplified nomogram to predict long-term survival after conversion chemotherapy followed by hepatectomy for initially unresectable colorectal liver metastases. (2015) (0)
Abstracts of the Joint 6th ELITA-ELTR (European Society for Organ Transplantation-European Liver and Intestine Transplant Association) 5th NHBD International Meeting. London, United Kingdom. May 13-15, 2010. (2010) (0)
Percutaneous cryosurgery of irresectable liver tumors (2001) (0)
Liver transplantation (LT) for alcoholic liver disease in adults in Europe (2008) (0)
The quality of life 10 years after liver transplantation (2000) (0)
First European phase II trial of intravenous (iv) cetuximab (Cet) and hepatic artery infusion (HAI) of irinotecan, 5-fluorouracil and oxaliplatin in patients with unresectable liver metastases from wt KRAS colorectal cancer (CRC) after systemic therapy failure (OPTILIV, NCT00852228). (2012) (0)
Living Donor Liver Transplantation: a European Liver Transplant Registry (eltr) Report On 1942 Cases (2008) (0)
Anastomosis porto-cava (2011) (0)
Appel à projets national en cancérologie 2013 Lettre d'intention / Letter of intent (2013) (0)
The effect of hepatic steatosis on survival following resection of colorectal liver metastases in patients without pre-operative chemotherapy [in revision] (2012) (0)
Hepatic Epithelioid Haemangio-Endothelioma and Adult Liver Transplantation: Extra-Hepatic Disease iI Not a Contraindication to Liver Transplantation. Report of the European Liver Transplant Registry Including 149 Patients (2016) (0)
Hepatic toxicity following systemic chemotherapy in a 65-year-old male with colorectal liver metastases (2007) (0)
Current Status of Liver Transplantation in Europe: An Analysis of Eltr Data (2009) (0)
Liver transplantation for iatrogenic bile duct injury during cholecystectomy: French retrospective multicentric study (2020) (0)
Outcome of pancreatoduodenectomy with venous resection and reconstruction in locally advanced pancreatic head cancer (2022) (0)
[Percutaneous destruction of hepatic tumors]. (2003) (0)
Conversion of Unresectable to Resectable Liver Metastases from Colorectal Carcinoma Using Hepatic Arterial Chronomodulated Chemotherapy: A Case Report and Short Literature Review (2018) (0)
Contents Vol. 25, 2008 (2009) (0)
Improved Survival in Liver Transplant Patients Receiving Prolonged-Release Tacrolimus (Advagraf): The European Liver Transplant Registry (ELTR) (2015) (0)
Liver re-transplantation (LReT) in children: analysis of European liver transplant registry over three decades (2011) (0)
Oncosurgical Strategies for Unresectable Liver Metastases (2009) (0)
703 Cryosurgery of non resectable malignant liver tumours (1995) (0)
Use of Bevacizumab in the Management of Potentially Resectable Colorectal Liver Metastases: Safety, Pathologic Assessment and Benefit (2016) (0)
Long-term outcome after R1 resection for colorectal liver metastases: Is a cure possible? (2015) (0)
Intraoperative Hypotension during Liver Transplant Surgery is Associated with Postoperative Acute Kidney: A Retrospective Cohort Study (2020) (0)
SECOND AND SUBSEQUENT LIVER RETRANSPLANTS IN EUROPE (2011) (0)
Risk factors associated with outcome in liver retransplantation: multicentric study. (2015) (0)
Towards an extension of the indications of liver transplantation (LT) for hepatocellular carcinoma with cirrhosis (2002) (0)
Liver transplantation for alpha-1 antitrypsin deficiency (2010) (0)
Erratum: Effect of specialist decision‐making on treatment strategies for colorectal liver metastases (2012) (0)
Minor hepatectomies: focusing a blurred picture. Analysis of the outcome of 4471 open resections in non-cirrhotic patients (2020) (0)
[I. Impact of Surgical Margin Status on Outcomes of Surgical Resection for Colorectal Liver Metastases]. (2018) (0)
Comment on “Long-Term Survival Benefit and Potential for Cure after R1 Resection for Colorectal Liver Metastases”: A Reply (2017) (0)
[154] SURVIVAL ANALYSIS OF HIV INFECTED PATIENTS REFERRED TO A LIVER TRANSPLANT UNIT (2007) (0)
Surgery for Nonresectable Metastatic Colorectal Cancer (2017) (0)
[Surgery of hepatic metastasis in colorectal cancers]. (2010) (0)
Risk factors of hepatectomy for colorectal liver metastases (CRLM) in the elderly. Preliminary data from LiverMetSurvey, the European colorectal liver metastasis resection registry. (2007) (0)
[Hepatic transplantation. The experience of Hôpital Paul-Brousse]. (1988) (0)
Drop-out between the two liver resections of two-stage hepatectomy for multiple bilobar colorectal metastases: Patient selection or loss of chance? (2015) (0)
Extended survival following liver resection for breast cancer metastases (2016) (0)
Outcome of split liver transplantation in Europe (ELTR database) (2006) (0)
WS-10-KL Oncosurgical management of colorectal liver metastases (2008) (0)
Phase II study of bevacizumab with liposomal doxorubicin for patients with platinum- and taxane-resistant ovarian cancer (2012) (0)
Is hepatic resection justified after chemotherapy in patients with colorectal liver metastases and lymph node involvement? (2009) (0)
Recurrent HCC: First indication for liver resections in liver transplantation recipients - 39 years of experience at an international reference center (2022) (0)
[Chemotherapy of liver metastasis from colorectal cancer]. (2007) (0)
Robustness of circadian rest-activity rhythm for predicting efficacy of intravenous cetuximab (Cet) and hepatic artery infusion (HAI) of chronomodulated irinotecan, 5-fluorouracil and oxaliplatin (Chrono-Optiliv) for liver metastases from colorectal cancer (LM-CRC) (Optiliv translational study, NCT0 (2013) (0)
TRENDS IN LIVER RETRANSPLANTATION IN EUROPE : EVALUATION OF THE LAST 28 YEARS (2011) (0)
CAVO-PORTAL AND RENO-PORTAL ANASTOMOSIS FOR LIVER TRANSPLANTATION IN PATIENTS WITH DIFFUSE PORTAL VEIN THROMBOSIS: LONG-TERM RESULTS IN 20 CONSECUTIVE PATIENTS FROM A SINGLE CENTRE: 524 (2010) (0)
Comment by R. Adam and H. Bismuth. (1995) (0)
464 CHARACTERISTICS AND PROGNOSIS OF FIBROSING CHOLESTATIC HEPATITIS AFTER LIVER TRANPLANTATION IN A LARGE COHORT OF HIV/HCV CO-INFECTED PATIENTS (2010) (0)
Metastatic Colorectal Cancer Bilobar Metastatic Disease That Has Completely Disappeared Following Systemic Chemotherapy (2020) (0)
[Key events from the 3rd Francophone Congress on Digestive and Hepatobiliary Surgery]. (2008) (0)
Are UK colorectal liver metastasis (CRLM) patients with bilobar (BLD) or resectable extra-hepatic disease (CREHD) less likely than their European counterparts to be referred for hepatectomy (HPX)? (2007) (0)
Reply to Rodriguez‐Peralvarez et al (2020) (0)
Perioperative outcomes in major liver resections for colorectal liver metastasis (CRLM) in the Elderly: a case-control matched study. (2015) (0)
Is ALPPS an alternative for patients with otherwise unresectable colorectal liver metastases (2016) (0)
LIVER TRANSPLANTATION IN POLYCYSTIC LIVER DISEASE : EXCELLENT SURVIVAL AND IMPROVEMENT OF QUALITY OF LIFE (2009) (0)
479 LIVER TRANSPLANTATION FOR ALPHA-1 ANTITRYPSIN DEFICIENCY: HEPATOCELLULAR CARCINOMA IS COMMON AND DETERIORATES SURVIVAL (2010) (0)
OP 01 EFFECTS OF RAPAMYCIN AND COBALT PROTOPORPHORINON INDUCTION OF HAEM OXYGENASE-1 AND ISCHEMIA REPERFUSION INJURY IN THE RAT LIVER (2010) (0)
[Role and technical aspects of surgery for liver metastases from urological malignancies]. (2008) (0)
Lessons from Collaborative Big Data—Insights from LiverMetSurvey Registry (2019) (0)
Extended cold ischaemia time and graft function after liver transplantation (1993) (0)
161 Albumin dialysis using the MARS® system in the treatment of patients with end-stage liver disease and renal failure (2006) (0)
Abstract P4-05-14: The PI3KCA mutations are frequent and remain along with recurrence of liver metastases from breast cancer in women who underwent up to 3 liver resections (2015) (0)
[Chemotherapy and surgery: how can resection of colorectal cancer metastases to the liver be optimized?]. (2008) (0)
Third ELITA‐ELTR Winter Meeting March 24–26, 2007 (2007) (0)
The European Liver Transplant Registry (ELTR): Improved Survival Outcomes in De Novo Liver Transplantation With Tacrolimus Prolonged Release (ADVAGRAF).: Abstract# A435 (2014) (0)
Risk Factors of Liver Transplantation and Donor To Recipient Matching: Impact On Outcomes in the European Liver Transplant Registry (eltr) (2009) (0)
[A new concept: induction chemotherapy in liver metastasis of colorectal origin]. (2004) (0)
Retransplantation of the liver: a reappraisal in the era of combined organ shortage and economical constraints (2002) (0)
EARLY DIAGNOSIS OF HEPATIC ARTERY THROMBOSIS AFTER LIVER TRANSPLANTATION WITH AN ICG- CLEARANCE NON-INVASIVE TECHNIQUE: 1642 (2008) (0)
TRENDS IN LIVER RETRANSPLANTATION IN EUROPE (2011) (0)
Small intrahepatic cholangiocarcinoma (iCCA) or hepatocholangiocarcinoma (HCA) on cirrhosis: liver transplantation (LT) versus resection (2015) (0)
Prediction of liver steatosis in liver transplant donors using liver to spleen attenuation ratio and BMI (2020) (0)
Influence of the ABO Blood Group System on Hepatocellular Carcinoma Recurrence After Liver Transplantation (2021) (0)
Answer to the Letter to Editor by Rodriguez-Peralvarez et al. (2020) (0)
INDICATIONS AND OUTCOMES OF PEDIATRIC LIVER RETRANSPLANTATION IN EUROPE. ANALYSIS OF A EUROPEAN LIVER REGISTRY-BASED COHORT (2019) (0)
Prevention of recurrence after liver transplantation for hepatocellular carcinoma (1996) (0)
Predictive model for microvascular invasion of hepatocellular carcinoma among candidates for either hepatectomy or liver transplantation. (2017) (0)
Chronological occurrence of PI3KCA mutations in breast cancer liver metastases after repeat partial liver resection (2019) (0)
IMPACT ON EARLY POST-OPERATIVE OUTCOME FOLLOWING LIVER TRANSPLANTATION OF GRAFTS LARGER THAN 2% OF THE RECIPIENTʼS BODY WEIGHT: 1732 (2010) (0)
1031 PROGNOSTIC FACTORS AT TEN YEARS AFTER LIVER TRANSPLANTATION FOR HEPATOCELLULAR CARCINOMA (2012) (0)
Impact of surgical margin according to AFP ratebefore hepatectomy for hepatocellular carcinoma (2018) (0)
Reply letter to: Simultaneous surgical treatment for both colorectal liver metastases and peritoneal carcinomatosis. (2014) (0)
THIRD LIVER TRANSPLANTATION: PREDICTIVE FACTORS OF SUCCESS: 1701 (2010) (0)
Are the Early Quality of Life Benefits Sustained Long-Term after Liver Transplantation? a 10-Year Longitudinal Diagnosis Stratified Evaluation (2016) (0)
445 Severe mitochondrial toxicity after liver transplantation in HIV-HCV coinfected patients (2003) (0)
Influence of cold ischemia time on outcome of human liver transplantation using UW solution (1993) (0)
Reply: (2011) (0)
Constitutive single nucleotide polymorphisms (SNP) assessment for predicting tolerability and efficacy of triplet hepatic artery infusion (HAI) and intravenous cetuximab (IV-CET) in patients (pts) with liver metastases from colorectal cancer (LM-CRC) (European trial OPTILIV, NCT00852228). (2014) (0)
UTILITY OF ROUTINE CT ARTERIOGRAPHY (CTA) IN THE DIAGNOSIS OF EARLY ARTERIAL COMPLICATIONS FOLLOWING ADULT LIVER TRANSPLANTATION: 1744 (2010) (0)
Synchronous Liver Metastasis Should not be an Absolute Contraindication for Curative Pancreaticoduodenectomy: A Report of 3 Cases with Good Long-term Survival (2020) (0)
ASO Author Reflections: Location of Microvascular Invasion in Hepatocellular Carcinoma—Intratumoral or Extratumoral Microvascular Invasion (2020) (0)
Major hepatectomy decreased tumor growth in an experimental model of bilobar liver metastasis. (2020) (0)
Invasive Aspergillosis After Liver Transplantation: Risk Factors, Morbidity and Prophylaxis: 2200 (2010) (0)
SECOND AND SUBSEQUENT LIVER RETRANSPLANTS IN EUROPE: ARE WE JUSTIFIED TO CONTINUE? (2011) (0)
Use of UW solution in liver transplantation: one year clinical results. (1989) (0)
[Oncosurgical strategies for metastatic liver cancer]. (2011) (0)
Indeterminate fulminant hepatitis: Clinico-pathological, immunological and virological reevaluation of the pre and post transplantation period of 31 cases transplanted since 1987 (2003) (0)
Liver transplantation: Predictive models for 3 and 12 month survival based on the ELTR registry (2005) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With René A. Adam?

René A. Adam is affiliated with the following schools:

René A. Adam's Academic­Influence.com Rankings

René A. Adam's Degrees

Why Is René A. Adam Influential?

René A. Adam's Published Works

Published Works

What Schools Are Affiliated With René A. Adam?

René A. Adam's AcademicInfluence.com Rankings